Abstract
Platelets contain a high level of taurine (10), and accumulate this neutral amino acid by an energy-dependent process (7). Taurine inhibits the aggregation induced by ADP (1), and hence is thought to modulate the platelet function.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Almazov, V.A., Gurerich, V.S., Mikhailova, I.A., and Streltaova, E.N., 1985, The influence of taurine on Ca2+, Mg2+, ATPase activity and aggregation of human platelet (Russian), Byull. Ekap. Biol. Med., 100:398–400.
Bennett, J., Thibaudeau, D., and Bessin, P., 1983, Dependency of the PAF-acether induced bronchospasm on the lipoxygenase pathway in the guinea pig, Prostaglandins, 26:457–466.
Chignard, M., LeCouedic, J.P., Tence, M., Vargaftig, B.B., and Benveniste, J., 1979, The role of platelet-activating factor in platelet aggregation, Nature, 279:799–800.
Darius, H., Lefer, D.J., Smith, J.B., and Lefer, A.M., 1986, Role of platelet-activating factor-acether in mediating guinea pig anaphylaxis, Science, 232:58–60.
Demopoulos, C.A., Pinckard, R.N., and Hanahan, D.J., 1979, Platelet activating factor. Evidence for 1-0-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators), J. Biol. Chem., 254:9355–9358.
Fitzgerald, M.F., Moncada, S., and Parente, L., 1986, The anaphylactic release of platelet-activating factor from perfused guinea pigs, Br. J. Pharmac., 88:149–153.
Gaut, Z.N., and Nauss, C.B., 1976, Uptake of taurine by human blood platelets: A plssible model for brain, in: “Taurine”, R. J. Huxtable and A. Barbeau eds., Raven Press, New York, pp. 91–98.
Hwang, S., Lam, M., Li, C, and Shen, T., 1986, Release of platelet activating factor and its involvement in the first phase of carrageenin-induced rat foot edema, Eur. J. Pharmac., 120:33–41.
Inarrea, P., Gomez-Cambronero, J., Nieto, M., and Crespo, M.S., 1984, Characteristics of the binding of platelet-activating factor to platelets of different animal species, Eur. J. Pharmac, 105:309–315.
Jacobsen, J.G., and Smith, L.H., 1968, Biochemistry and physiology of taurine and taurine derivatives, Physiol. Rev., 48:424–511.
Konzett, H., and Rossler, R., 1940, Verschsanordnung zu Utersuchungen an der Bronchialmuskulatur, Naunyn-Schmiedebergs Arch. Exp. Path. Pharmak., 195:71.
Lee, T-C., Mlone, B., Blank, M.L., and Snyder, F., 1981, l-Alkyl 2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor) stimulates calcium influx in rabbit platelet, Biochem. Biophys. Res. Commun., 102:1262–1268.
Maridonneau-Parini, I., Lagente, V., Lefort, J., Russo-Marie, F., and Vargaftig, B.B., 1985, Desensitization to PAF-induced bronchoconstriction and to activation of th alveolar macrophages by repeated inhalations of PAF in the guinea pig, Biochem. Biophys. Res. Commun., 131:42–49.
Namm, D.H., Tadepalli, A.S., and High, J.A., 1982, Species specificity of the platelet responses to l-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine, Thromb. Res., 25:341–350.
Robertson, D.N., and Smith, G.M., 1986, Cv88 inhibits in vivo platelet aggregation induced by PAF-acether and collagen, Eur. J. Pharmac, 123:91–97.
Shaw, J.O., Klusick, S.J., and Hanahan, D.J., 1981, Activation of rabbit platelet phospholipase and thromboxane synthesis by 1-0-hexadecy1/-octadecyl-2-acetyl-2-sn-glyceryl-3-phosphorylcholine (platelet activating factor), Biochem. Biophys. Acta, 663:222–229.
Vargaftig, B.B., and Benveniste, J., 1983, Platelet-activating factor today, Trends Pharmacol. Sci., 4:341–344.
Vargaftig, B.B., Chignard, M., Benveniste, J., Lefort, J., and Wal, F., 1981, Background and present status of research on platelet-activating factor (PAF-acether), Ann. N. Y. Acad. Sci., 370:119–137.
Vargaftig, B.B., Lefort, J., Chignard, M., and Benveniste, J., 1980, Platelet-activating factor induces a platelet-dependent broncho-constriction unrelated to the formation of prostaglandin derivatives, Eur. J. Pharmac., 65:185–192.
Young, J.M., Maloney, P.J., Jobb, S.N., and Clark, J.S., 1985, Pharmacological investigation of the mechanisms of platelet-activating factor induced mortality in the mouse, Prostaglandins, 30:545–551.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Springer Science+Business Media New York
About this chapter
Cite this chapter
Kurachi, M., Hongoh, K., Watanabe, A., Aihara, H. (1987). Suppression of Bronchial Response to Platelet Activating Factor Following Taurine Administration. In: Huxtable, R.J., Franconi, F., Giotti, A. (eds) The Biology of Taurine. Advances in Experimental Medicine and Biology, vol 217. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0405-8_20
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0405-8_20
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0407-2
Online ISBN: 978-1-4899-0405-8
eBook Packages: Springer Book Archive